Chinese Medicine Research Center, China Medical University, Taichung, 404, Taiwan.
Research Center for Chinese Herbal Medicine, China Medical University, Taichung, 404, Taiwan.
Neurotherapeutics. 2019 Jul;16(3):891-900. doi: 10.1007/s13311-019-00722-7.
Debates regarding the most beneficial medical or surgical procedures for patients with spontaneous intracerebral hemorrhage (sICH) are still ongoing. We aimed to evaluate the risk of subsequent vascular disease and mortality in patients with sICH treated with and without surgical intervention, in a large-scale Asian population. Patients hospitalized within 2000 to 2013 who were newly diagnosed with sICH were identified using the National Health Insurance Research Database of Taiwan. Neuroendoscopy and craniotomy groups comprised patients who underwent surgical treatment within 1 week, while those in the control group did not undergo early surgical treatment. Outcomes included subsequent hemorrhagic and ischemic stroke, following acute myocardial infarction, congestive heart failure, and mortality. After propensity score matching, there were 663 patients in each group. Compared to that in the control group, the neuroendoscopy and craniotomy groups had a significantly higher risk of secondary vascular events at 1 to 3 months of follow-up (adjusted HR, 2.08 and 1.95; 95% CI, 1.21-3.58 and 1.13-3.35; p < 0.01 and p < 0.05, respectively), but a significantly lower risk after 3 years of follow-up (adjusted HR, 0.52 and 0.52; 95% CI, 0.35-0.78 and 0.35-0.77; p < 0.01 and p < 0.01, respectively). The mortality rate was higher in the craniotomy group at 6 to 12 months of follow-up (adjusted HR, 2.18; 95% CI, 1.06-4.49; p < 0.05) compared to that in the control group. Thus, a timely surgical intervention for hematoma evacuation is advantageous in preventing secondary vascular events and improving outcomes in the long term. However, greater attention to secondary ischemic stroke following the initial sICH episode is needed.
关于自发性脑出血(sICH)患者最有益的医疗或手术程序的争论仍在继续。我们旨在评估在大规模亚洲人群中,接受和不接受手术干预的 sICH 患者发生后续血管疾病和死亡的风险。使用台湾全民健康保险研究数据库,确定了 2000 年至 2013 年期间住院的新诊断为 sICH 的患者。神经内镜和开颅手术组的患者在 1 周内接受了手术治疗,而对照组患者未接受早期手术治疗。结果包括急性心肌梗死后的继发性出血性和缺血性卒中、充血性心力衰竭和死亡率。经过倾向评分匹配后,每组各有 663 例患者。与对照组相比,神经内镜和开颅手术组在随访 1 至 3 个月时发生继发性血管事件的风险显著更高(校正后的 HR,2.08 和 1.95;95%CI,1.21-3.58 和 1.13-3.35;p<0.01 和 p<0.05),但在随访 3 年后风险显著降低(校正后的 HR,0.52 和 0.52;95%CI,0.35-0.78 和 0.35-0.77;p<0.01 和 p<0.01)。开颅手术组在随访 6 至 12 个月时的死亡率高于对照组(校正后的 HR,2.18;95%CI,1.06-4.49;p<0.05)。因此,及时进行血肿清除手术有利于预防继发性血管事件,并在长期内改善预后。然而,需要更加关注初始 sICH 发作后的继发性缺血性卒中。